ArticleScientific reports2017

Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolism.

Mohammed A Sarhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.